108 related articles for article (PubMed ID: 12017217)
21. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.
L'Hermite M
Climacteric; 2013 Aug; 16 Suppl 1():44-53. PubMed ID: 23848491
[TBL] [Abstract][Full Text] [Related]
22. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
[TBL] [Abstract][Full Text] [Related]
23. Spotlight on estradiol-intranasal in the management of menopause.
Dooley M; Spencer CM; Ormrod D
Treat Endocrinol; 2002; 1(3):191-4. PubMed ID: 15799211
[TBL] [Abstract][Full Text] [Related]
24. Osteoporosis prevention clinical study program.
Delmas P; Gimona A
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
[TBL] [Abstract][Full Text] [Related]
25. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
Sajtos B; Herold J; Winkler UH; Schindler AE
Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
[TBL] [Abstract][Full Text] [Related]
27. [A transdermal therapeutic system for hormonal therapy of climacteric deficiency pictures. A multicenter study].
Kerzel C; Keller PJ
Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):565-8. PubMed ID: 3653671
[TBL] [Abstract][Full Text] [Related]
28. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
Genazzani AR; Cappagli B; Ciaponi M
Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation, dose-finding and acceptability of AERODIOL, the pulsed estrogen therapy for treatment of climacteric symptoms.
Pelissier C; de Kervasdoue A; Chuong VT; Maugis EL; de Mouillac F; Breil MH; Moniot G; Zeitoun-Lepvrier G; Robin M; Rime B
Maturitas; 2001 Jan; 37(3):181-9. PubMed ID: 11173180
[TBL] [Abstract][Full Text] [Related]
30. Changes in menopausal symptoms comparing oral estradiol versus transdermal estradiol.
Tang R; Xie Z; Ruan X; Zhang Z; Ren M; Wu J; Shu K; Shi H; Xie M; Lv S; Yang X; Chen R; Yu Q
Climacteric; 2024 Apr; 27(2):171-177. PubMed ID: 37942806
[TBL] [Abstract][Full Text] [Related]
31. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations.
Mattsson LA; Bohnet HG; Gredmark T; Torhorst J; Hornig F; Hüls G
Obstet Gynecol; 1999 Jul; 94(1):61-5. PubMed ID: 10389719
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparison of intranasal and transdermal estradiol.
Lopes P; Merkus HM; Nauman J; Bruschi F; Foidart JM; Calaf J
Obstet Gynecol; 2000 Dec; 96(6):906-12. PubMed ID: 11084176
[TBL] [Abstract][Full Text] [Related]
33. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
Mizunuma H
Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
[TBL] [Abstract][Full Text] [Related]
34. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
[TBL] [Abstract][Full Text] [Related]
35. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
36. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women.
De Leo V; Lanzetta D; Morgante G; De Palma P; D'Antona D
Contraception; 1997 Apr; 55(4):239-43. PubMed ID: 9179456
[TBL] [Abstract][Full Text] [Related]
39. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
40. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.
Rohr UD; Volko CD; Schindler AE
Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
